Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
spondyloepiphyseal dysplasia with congenital joint dislocations
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
08/04/2025
Evidence/Notes:

CHST3 was first reported in relation to autosomal recessive chondrodysplasia with congenital joint dislocations (SEDCJD) in 2004 (Thiele et al. 2004, PMID: 15215498). SEDCJD, also known as CHST3-related skeletal dysplasia is a rare bone disorder characterized by short stature of prenatal onset; dislocation of the knees, hips or elbows; club feet; limitation of range of motion of large joints; progressive kyphosis; and occasional scoliosis. Intellect, vision and hearing are normal. A total of thirteen unique variants (missense, nonsense, frameshift, indel) that have been reported in eleven probands in five publications (PMIDs: 15215498, 18513679, 29453417, 36729370, 37876363) are included in this curation. Variants in this gene segregated in eight additional family members (PMID: 15215498, 37876363). More genetic evidence is available in the literature, however, the maximum score (12pts) has been reached. The mechanism of pathogenicity is predicted to be loss-of-function. This gene-disease relationship is also supported by functional alteration studies in patient cells (PMID: 18513679). In summary, there is definitive evidence supporting the relationship between CHST3 and autosomal recessive chondrodysplasia with congenital joint dislocations. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date August 4th, 2025 (SOP Version 11).

PubMed IDs:
15215498 18513679 29453417 36729370 37876363
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.